InvestorsHub Logo

Hugon

10/31/21 4:25 PM

#380748 RE: bradfordbros #380747

With that logic you fail to understand timeline for rest of indications and big pharma confidence in Brilacidin tod date and you also might fail to understand IP all Indications post Covid.

Covid is the mark. Focus. Don’t deflect for another 1-2 years of clinical trial work in other indications. Wtf